WHO Classification of Tumours Editorial Board. WHO Classification of Tumours of Soft Tissue and Bone. 5th ed. Lyon: IARC Press; 2020.
[2]
Cai Z, Tang X, Liang H, et al. Diagnosis and treatment of malignant peripheral nerve sheath tumors in the spine and pelvis: A systematic review. J Neurooncol. 2021;155(2):245-255.
[3]
Farid M, Demicco EG, Garcia R, et al. Malignant peripheral nerve sheath tumors. Oncologist. 2014;19(2):193-201.
[4]
Kroep JR, Maurice C, Rouleau RM, et al. First-line chemotherapy for malignant peripheral nerve sheath tumor (MPNST) and other soft tissue sarcomas. Crit Rev Oncol Hematol. 2012;83(3):369-380.
[5]
Stucky CC, Johnson KN, Gray RJ, et al. Malignant peripheral nerve sheath tumors (MPNST): the Mayo Clinic experience. Ann Surg Oncol. 2012;19(3):878-885.
[6]
James AW, Shurell E, Singh A, et al. Malignant peripheral nerve sheath tumor. Surg Oncol Clin N Am. 2016;25(4):789-802.
[7]
Katz D, Lazar A, Lev D. Malignant peripheral nerve sheath tumour. Ann Oncol. 2009;20(Suppl 4):iv23-iv26.
[8]
Porter DE, Prasad V, Foster L, et al. Survival in malignant peripheral nerve sheath tumours: A comparison between sporadic and neurofibromatosis type 1-associated tumours. Sarcoma. 2009;2009:756395.